Repligen to Report Third Quarter 2025 Financial Results

Core Points - Repligen Corporation will report its third quarter 2025 financial results on October 28, 2025, with a conference call scheduled for 8:30 a.m. ET to discuss business updates and financial results for the three- and nine-month periods ended September 30, 2025 [1] - The conference call will be accessible via toll-free numbers for domestic and international callers, and a webcast will be available on the company's Investor Relations website [2] - Repligen Corporation is a global life sciences company focused on developing innovative bioprocessing technologies for the manufacturing of biological drugs, serving biopharmaceutical developers and contract development and manufacturing organizations (CDMOs) [3]